About Nevoa – as seen on Fox Business Network
October 15 and 18, 2020
Take just 60 seconds to watch the short story of Nevoa® and
our whole room disinfecting robot, Nimbus™.
Nevoa is now accepting orders through the GHX platform.
The only patented, hospital-grade surface disinfecting system approved for fogging EPA-registered Hypochlorous acid (HOCl).
Nevoa invented Nimbus, a robot that fogs our Microburst™ disinfectant solution throughout a hospital patient room. This unique robotic technology, combined with the efficacy of Hypochlorous acid, eliminate the human error associated with manual cleaning, and allow hospitals and healthcare facilities to completely disinfect patient rooms and other areas.
Independent studies and laboratory testing have proved that Nimbus + Microburst is greater than 99.99% effective at killing pathogens and viruses that cause Healthcare-acquired Infections (HAIs). These include pathogens such as MRSA, Staph, and C. difficile – as well as Rhinovirus and Norovirus, which are lab-recommended surrogates for SARS-CoV-2, the virus which causes coronavirus disease (COVID-19).
The recent coronavirus outbreak has elevated awareness regarding the importance of disinfection. But COVID-19 isn’t the only threat, so we’re fighting them all.
Nevoa started with a simple idea: let’s invent a better and more affordable way to save lives through disinfection – and allow healthcare professionals to live by their credo and “do no harm.”